Singer Robbie Williams admits in an interview with The Sun to having blurry vision and said that it is 'getting worse,' and ...

GLP-1 medications like Ozempic, Zepbound and Wegovy are revolutionizing weight management, but with their growing popularity ...

Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.

Novo Nordisk's top shareholder forced through an overhaul of the Wegovy-maker's board at an extraordinary shareholder meeting ...

Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

Real users give insights on taking GLP-1 medications for weight loss, including experiences with benefits, stigma, side ...